References

Expanding opportunities for living donation: Recommendations from the 2023 santander summit to ensure donor protections, informed decision making and equitable access

10.1097/tp.0000000000005124 · 2025 · External reference

KDIGO clinical practice guideline on the evaluation and care of living kidney donors

10.1097/tp.0000000000001769 · 2017 · External reference

Donor and recipient views on their relationship in living kidney donation: Thematic synthesis of qualitative studies

10.1053/j.ajkd.2016.09.017 · 2017 · External reference

A previous miscarriage and a previous successful pregnancy have a different impact on HLA antibody formation during a subsequent successful pregnancy

10.3389/fimmu.2016.00571 · 2016 · External reference

Toward an understanding of allogeneic conflict in pregnancy and transplantation

10.1084/jem.20211493 · 2022 · External reference

Snowflake epitope matching correlates with child-specific antibodies during pregnancy and donor-specific antibodies after kidney transplantation

10.3389/fimmu.2022.1005601 · 2022 · External reference

Outcome of husband-to-wife kidney transplantation with mutual children: Single center experience using T cell-depleting induction and review of the literature

10.3389/fmed.2021.724851 · 2021 · External reference

Accelerated rejection following offspring‐to‐mother and husband‐to‐wife transplants

10.1111/j.1399-0012.2004.00250.x · 2004 · External reference

A case of accelerated acute rejection after ABO‐compatible living unrelated kidney transplantation

10.1111/j.1399-0012.2009.01004.x · 2009 · External reference

Single antigen testing to reduce early antibody-mediated rejection risk in female recipients of a spousal donor kidney

10.1016/j.trim.2021.101407 · 2021 · External reference

Outcomes of living-donor kidney transplantation in female recipients with possible pregnancy-related pre-sensitization according to donor relationship

10.12659/aot.925229 · 2020 · External reference

Impact of sex on clinical outcomes according to immunologic risk in spousal donor kidney transplantation

10.23876/j.krcp.24.128 · 2026 · External reference

Comparing outcomes of spousal kidney transplants with living-related donors in DSA-positive recipients: Is the risk increased in husband-to-wife donation

10.1159/000549594 · 2025 · External reference

Clinicopathological analysis of immunologically high-risk kidney transplantation using high-dose intravenous immunoglobulin as desensitization therapy

10.1159/000548263 · 2025 · External reference

Biologic mechanisms and clinical consequences of pregnancy alloimmunization

10.1111/ajt.14673 · 2018 · External reference

Memory B cells in pregnancy sensitization

10.3389/fimmu.2021.688987 · 2021 · External reference

Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation

10.1097/tp.0b013e31827a19cc · 2013 · External reference

Sensitization in transplantation: Assessment of risk (STAR) 2019 working group meeting report

10.1111/ajt.15937 · 2020 · External reference

Frequency and determinants of pregnancy-induced child-specific sensitization

10.1111/ajt.12048 · 2013 · External reference

The clinical utility of post-transplant monitoring of donor-specific antibodies in stable renal transplant recipients: A consensus report with guideline statements for clinical practice

10.3389/ti.2023.11321 · 2023 · External reference

Predicted indirectly recognizable HLA epitopes presented by HLA-DRB1 are related to HLA antibody formation during pregnancy

10.1111/ajt.13508 · 2015 · External reference

Writing narrative literature reviews for peer-reviewed journals: Secrets of the trade

10.1016/s0899-3467(07)60142-6 · 2006 · External reference

Narrative reviews: Flexible, rigorous, and practical

10.4300/jgme-d-22-00480.1 · 2022 · External reference

Toward defining the immunogenicity of HLA epitopes: impact of HLA class I eplets on antibody formation during pregnancy

10.1111/tan.14054 · 2020 · External reference

Peptides derived from mismatched paternal human leukocyte antigen predicted to be presented by HLA-DRB1, -DRB3/4/5, -DQ, and -DP induce child-specific antibodies in pregnant women

10.3389/fimmu.2021.797360 · 2021 · External reference

The banff 2017 kidney meeting report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for integrative endpoints for next‐generation clinical trials

10.1111/ajt.14625 · 2018 · External reference

Offspring-to-mother and husband-to-wife renal transplantation: A single-center experience

10.1016/j.transproceed.2007.11.062 · 2008 · External reference

Women recipients are at high risk for biopsy-proven acute rejection in spouse kidney transplantation

10.1016/j.trim.2025.102324 · 2025 · External reference

Renal transplant outcomes in spousal and living-related donors in Malaysia

10.47102/annals-acadmedsg.v48n12p403 · 2019 · External reference

Transplantation rénale entre époux et immunisation anti-HLA en prégreffe: à propos de deux observations

10.11604/pamj.2021.40.92.18744 · 2021 · External reference

Longitudinal assessment of HLA and MIC-a antibodies in uneventful pregnancies and pregnancies complicated by preeclampsia or gestational diabetes

10.1038/s41598-017-13275-6 · 2017 · External reference

The when, what, and where of naturally-acquired microchimerism

10.1007/s00281-024-01029-2 · 2025 · External reference

Pregnancy promotes tolerance to future offspring by programming selective dysfunction in long-lived maternal T cells

10.1189/jlb.1a0316-135r · 2017 · External reference

Epitopes as characterized by antibody-verified eplet mismatches determine risk of kidney transplant loss

10.1016/j.kint.2019.10.028 · 2020 · External reference

High maternal-fetal HLA eplet compatibility is associated with severe manifestation of preeclampsia

10.3389/fimmu.2023.1272021 · 2023 · External reference

Pregnancy-induced humoral sensitization overrides T cell tolerance to fetus-matched allografts in mice

10.1172/jci140715 · 2021 · External reference

Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation

10.1681/asn.2009101065 · 2010 · External reference

Pretransplant donor-specific anti-HLA antibodies and the risk for rejection-related graft failure of kidney allografts

10.1155/2020/5694670 · 2020 · External reference

Positive luminex and negative flow cytometry in kidney transplantation: A systematic review and meta-analysis

10.1093/ndt/gfy349 · 2019 · External reference

Sensitive HLA antibody testing and the risk of antibody‐mediated rejection and graft failure

10.1111/tan.15586 · 2024 · External reference

The relationship of microvascular inflammation with antibody-mediated rejection in kidney transplantation

10.1016/j.ajt.2024.07.023 · 2025 · External reference

A memory B cell crossmatch assay for quantification of donor-specific memory B cells in the peripheral blood of HLA-immunized individuals

10.1111/ajt.14293 · 2017 · External reference

Alloreactive memory B cell detection by flow cytometric cross match using polyclonally activated memory B cell culture supernatants

10.1016/j.trim.2022.101642 · 2022 · External reference

A multicolour HLA-specific B-cell FluoroSpot assay to functionally track circulating HLA-specific memory B cells

10.1016/j.jim.2018.07.011 · 2018 · External reference

Glycolysis changes in alloreactive memory B cells in highly sensitized kidney transplant recipients undergoing desensitization therapy

10.3389/ti.2024.13029 · 2024 · External reference

Memory B‐cell assay uncovers prior HLA sensitisation in transplant candidates with prior exposure to non‐self HLA

10.1111/tan.70393 · 2025 · External reference

Memory B-cell derived donor-specific antibodies do not predict outcome in sensitized kidney transplant recipients: A retrospective single-center study

10.3389/fimmu.2024.1360627 · 2024 · External reference

Preformed circulating HLA-specific memory B cells predict high risk of humoral rejection in kidney transplantation

10.1038/ki.2015.205 · 2015 · External reference

HLA‐specific memory B‐cell detection in kidney transplantation: Insights and future challenges

10.1111/iji.12493 · 2020 · External reference

New therapies for highly sensitized patients on the waiting list

10.34067/kid.0000000000000509 · 2024 · External reference

Translating B cell immunology to the treatment of antibody-mediated allograft rejection

10.1038/s41581-023-00791-0 · 2024 · External reference

Isatuximab monotherapy for desensitization in highly sensitized patients awaiting kidney transplant

10.1681/asn.0000000000000287 · 2024 · External reference

Effects of in vivo CXCR4 blockade and proteasome inhibition on bone marrow plasma cells in HLA-sensitized kidney transplant candidates

10.1016/j.ajt.2023.02.022 · 2023 · External reference

Anti-HLA serologic response to CD38-targeting desensitization therapy is challenged by peripheral memory B cells in highly sensitized kidney transplant candidates

10.1016/j.ajt.2024.08.004 · 2025 · External reference

B-cell maturation antigen-targeted T-cell engager therapy combined with B-cell depletion for treatment of refractory HLA sensitization

10.1016/j.kint.2026.01.020 · 2026 · External reference

Chronic rejection after kidney transplantation

10.1097/tp.0000000000005187 · 2025 · External reference

Donor-specific B cell memory in alloimmunized kidney transplant recipients: First clinical application of a novel method

10.1097/tp.0000000000002909 · 2020 · External reference

Low-MFI (median fluorescence intensity) pre-transplant DSA (donor specific antibodies) leading to anamnestic antibody mediated rejection in live-related donor kidney transplantation

10.1016/j.trim.2023.101931 · 2023 · External reference

Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant

10.1111/j.1600-6143.2012.04013.x · 2012 · External reference

Incidence and impact of de novo donor-specific alloantibody in primary renal allografts

10.1097/tp.0b013e31827d62e3 · 2013 · External reference

A randomized phase 2 trial of felzartamab in antibody-mediated rejection

10.1056/nejmoa2400763 · 2024 · External reference

Targeting CD38 in antibody-mediated rejection

10.3389/ti.2025.14343 · 2025 · External reference

Microvascular inflammation in kidney allografts: New directions for patient management

10.1016/j.ajt.2025.03.031 · 2025 · External reference

De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure

10.1111/j.1600-6143.2009.02800.x · 2009 · External reference

The banff 2019 kidney meeting report (I): Updates on and clarification of criteria for T cell- and antibody-mediated rejection

10.1111/ajt.15898 · 2020 · External reference

The banff 2022 kidney meeting report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics

10.1016/j.ajt.2023.10.016 · 2024 · External reference

Microvascular inflammation of kidney allografts and clinical outcomes

10.1056/nejmoa2408835 · 2025 · External reference

Complement-binding anti-HLA antibodies and kidney-allograft survival

10.1056/nejmoa1302506 · 2013 · External reference

Detection of C3D-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss

10.1681/asn.2013101144 · 2015 · External reference

Natural killer cell functional genetics and donor-specific antibody-triggered microvascular inflammation

10.1016/j.ajt.2023.12.005 · 2024 · External reference

Microvascular inflammation in the absence of human leukocyte antigen-donor-specific antibody and C4d: An orphan category in banff classification with cytotoxic T and natural killer cell infiltration

10.1016/j.ajt.2022.12.018 · 2023 · External reference

Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants

10.1038/s41467-019-13113-5 · 2019 · External reference

The perfect storm: HLA antibodies, complement, FcγRs and endothelium in transplant rejection

10.1016/j.molmed.2015.02.004 · 2015 · External reference

IgG donor-specific anti-human HLA antibody subclasses and kidney allograft antibody-mediated injury

10.1681/asn.2014111120 · 2016 · External reference

Endothelial dysfunction in kidney transplantation

10.3389/fimmu.2018.01130 · 2018 · External reference

Recommended treatment for antibody-mediated rejection after kidney transplantation: The 2019 expert consensus from the transplantion society working group

10.1097/tp.0000000000003095 · 2020 · External reference

Sensitization in transplantation: Assessment of risk 2022 working group meeting report

10.1016/j.ajt.2022.11.009 · 2023 · External reference

Clinical recommendations for posttransplant assessment of anti–HLA (human leukocyte antigen) donor-specific antibodies: A sensitization in transplantation: assessment of risk consensus document

10.1016/j.ajt.2022.11.013 · 2023 · External reference

KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation

10.1097/tp.0000000000003136 · 2020 · External reference

Points to consider: Ethical, legal, and psychosocial implications of genetic testing in children and adolescents

10.1016/j.ajhg.2015.05.022 · 2015 · External reference

HLA‐DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity

10.1111/ajt.15177 · 2019 · External reference

Donor–recipient matching based on predicted indirectly recognizable HLA epitopes independently predicts the incidence of de novo donor-specific HLA antibodies following renal transplantation

10.1111/ajt.14393 · 2017 · External reference

The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

10.1136/bmj.n71 · 2021 · External reference

GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables

10.1016/j.jclinepi.2010.04.026 · 2011 · External reference

Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation

10.1016/j.kint.2018.08.027 · 2019 · External reference